GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » YoY Rev. per Sh. Growth

Square Pharmaceuticals (DHA:SQURPHARMA) YoY Rev. per Sh. Growth : 14.52% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Square Pharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was 14.52%.

Square Pharmaceuticals's Revenue per Share for the three months ended in Dec. 2023 was BDT20.90.


Square Pharmaceuticals YoY Rev. per Sh. Growth Historical Data

The historical data trend for Square Pharmaceuticals's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals YoY Rev. per Sh. Growth Chart

Square Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.05 4.19 10.52 13.60 8.94

Square Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.96 6.74 5.25 14.87 14.52

Square Pharmaceuticals YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Square Pharmaceuticals's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2023 )
=(Revenue per Share (A: Jun. 2023 )-Revenue per Share (A: Jun. 2022 ))/ | Revenue per Share (A: Jun. 2022 ) |
=(70.785-64.976)/ | 64.976 |
=8.94 %

Square Pharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(20.902-18.252)/ | 18.252 |
=14.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Square Pharmaceuticals YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Square Pharmaceuticals's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Square Pharmaceuticals (DHA:SQURPHARMA) Business Description

Traded in Other Exchanges
N/A
Address
Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs.

Square Pharmaceuticals (DHA:SQURPHARMA) Headlines

No Headlines